Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Sep-24 9:20 PM View:  | Travere Therapeutics, Inc. (TVTX) | 09-Sep-24 | Sale | 2,191 | $11.52 | $25,240.30 | (2%) 110.15K to 107.96K | |
| 09-Sep-24 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-24 | Grant | 6,750 | -- | -- | 7% 103.4K to 110.15K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale | 4,195 | $8.53 | $35,788.80 | (4%) 103.7K to 99.5K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-24 | Grant | 25,000 | -- | -- | 32% 78.7K to 103.7K | |
| 25-Jan-24 4:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Jan-24 | Sale | 1,559 | $9.07 | $14,137.60 | (2%) 80.26K to 78.7K | |
| 04-Oct-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Oct-23 | Sale | 3,091 | $8.25 | $25,504.10 | (4%) 83.35K to 80.26K | |
| 02-Feb-23 7:04 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-23 | Sale | 1,779 | $21.75 | $38,696.80 | (2%) 83.85K to 82.07K | |
| 02-Feb-23 7:04 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-23 | Grant | 20,250 | -- | -- | 32% 63.6K to 83.85K | |
| 26-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-23 | Sale | 1,550 | $21.90 | $33,951.80 | (2%) 65.15K to 63.6K | |
| 06-Oct-22 8:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Oct-22 | Market Sale | 3,042 | $25.68 | $78,118.60 | (4%) 68.19K to 65.15K | (9%) |
| 02-Feb-22 4:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Grant | 9,840 | -- | -- | 17% 58.58K to 68.42K | |
| 02-Feb-22 4:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Sale (Planned) | 1,125 | $27.40 | $30,825.00 | (2%) 68.42K to 67.3K | |
| 26-Jan-22 4:36 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-22 | Market Sale (Planned) | 1,875 | $24.98 | $46,837.50 | (3%) 60.46K to 58.58K | (12%) |
| 05-Oct-21 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Oct-21 | Market Sale | 3,058 | $24.77 | $75,746.00 | (5%) 63.52K to 60.46K | (< 1%) |
| 17-Aug-21 7:41 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-Aug-21 | Market Sale | 1,407 | $17.12 | $24,086.00 | (2%) 64.92K to 63.52K | |
| 17-Aug-21 7:41 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-Aug-21 | Grant | 4,500 | -- | -- | 7% 60.42K to 64.92K | |
| 09-Feb-21 4:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Feb-21 | Market Sale (Planned) | 1,125 | $31.58 | $35,527.50 | (2%) 60.47K to 59.34K | 2% |
| 09-Feb-21 4:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Feb-21 | Market Sale (Planned) | 1,125 | $31.41 | $35,336.20 | (2%) 61.59K to 60.47K | (1%) |
| 05-Feb-21 4:48 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Grant | 4,500 | -- | -- | 8% 57.09K to 61.59K | |
| 03-Feb-21 9:33 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Market Sale (Planned) | 563 | $28.91 | $16,276.30 | (< 1%) 57.66K to 57.09K | (5%) |
| 03-Feb-21 9:33 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Sale (Planned) | 563 | $30.75 | $17,312.20 | (< 1%) 58.22K to 57.66K | 6% |
| 25-Jan-21 8:55 PM View: | Travere Therapeutics, Inc. (TVTX) | 21-Jan-21 | Grant | 15,000 | -- | -- | 35% 43.22K to 58.22K | |
| 05-Oct-20 8:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Oct-20 | Market Sale (Planned) | 2,188 | $19.35 | $42,337.80 | (5%) 44.52K to 42.33K | (< 1%) |
| 05-Oct-20 8:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Oct-20 | Market Sale (Planned) | 2,188 | $18.90 | $41,353.20 | (5%) 46.7K to 44.52K | (2%) |
| 31-Jan-20 8:16 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-20 | Grant | 9,000 | -- | -- | 26% 35.0K to 44.0K | |
| 02-Oct-19 8:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Oct-19 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K |